Literature DB >> 11880958

Delayed reimplantation arthroplasty for candidal prosthetic joint infection: a report of 4 cases and review of the literature.

David M Phelan1, Douglas R Osmon, Michael R Keating, Arlen D Hanssen.   

Abstract

Fungal prosthetic joint infection (PJI) is rare, with Candida species being the most frequently reported pathogen in the medical literature. The risk of relapse following delayed reimplantation arthroplasty for candidal PJI is unknown. We describe 4 new cases and summarize 6 previously reported cases of candidal PJI treated with delayed reimplantation arthroplasty. Ninety percent of the patients received antifungal therapy. Eight patients received amphotericin B either alone or in combination with other antifungals. One patient received fluconazole alone. The median duration of time from resection arthroplasty to reimplantation for total hip and total knee arthroplasties was 8.6 and 2.3 months, respectively. Eight patients did not have relapse of candidal PJI following delayed reimplantation arthroplasty after a median duration of follow-up of 50.7 months (range, 2--73 months). Candidal PJI can be successfully treated with delayed reimplantation arthroplasty after receipt appropriate antifungal therapy.

Entities:  

Mesh:

Year:  2002        PMID: 11880958     DOI: 10.1086/339212

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  29 in total

1.  Staged Reimplantation of a Total Hip Prosthesis After Co-infection with Candida tropicalis and Staphylococcus haemolyticus: A Case Report.

Authors:  Sujeesh Sebastian; Rajesh Malhotra; Ashish Pande; Deepak Gautam; Immaculata Xess; Benu Dhawan
Journal:  Mycopathologia       Date:  2017-07-22       Impact factor: 2.574

2.  The Zeitgeist of Challenging the Evidence. A Perspective on the International Consensus Meeting on Periprosthetic Joint Infection.

Authors:  Hangama C Fayaz; Jesse B Jupiter
Journal:  Arch Bone Jt Surg       Date:  2017-01

3.  Candida glabrata: an unusual fungal infection following a total hip replacement.

Authors:  Rebecca Louise Hall; Rebecca Meghan Frost; Nijil Lal Vasukutty; Hasnat Minhas
Journal:  BMJ Case Rep       Date:  2012-09-24

4.  In vitro activity of caspofungin against Candida albicans biofilms.

Authors:  Stefano P Bachmann; Kacy VandeWalle; Gordon Ramage; Thomas F Patterson; Brian L Wickes; John R Graybill; José L López-Ribot
Journal:  Antimicrob Agents Chemother       Date:  2002-11       Impact factor: 5.191

5.  Candida periprosthetic infection of the hip: a systematic review of surgical treatments and clinical outcomes.

Authors:  Federico Fusini; Alessandro Aprato; Alessandro Massè; Alessandro Bistolfi; Massimo Girardo; Stefano Artiaco
Journal:  Int Orthop       Date:  2019-06-28       Impact factor: 3.075

Review 6.  Candida albicans prosthetic hip infection in elderly patients: is fluconazole monotherapy an option?

Authors:  Theodoros Kelesidis; Sotirios Tsiodras
Journal:  Scand J Infect Dis       Date:  2010

7.  What is the success of treatment of hip and knee candidal periprosthetic joint infection?

Authors:  Steve W N Ueng; Ching-Yu Lee; Chih-chien Hu; Pang-Hsin Hsieh; Yuhan Chang
Journal:  Clin Orthop Relat Res       Date:  2013-04-30       Impact factor: 4.176

Review 8.  Prosthetic joint infection.

Authors:  Aaron J Tande; Robin Patel
Journal:  Clin Microbiol Rev       Date:  2014-04       Impact factor: 26.132

9.  Italian guidelines for the diagnosis and infectious disease management of osteomyelitis and prosthetic joint infections in adults.

Authors:  S Esposito; S Leone; M Bassetti; S Borrè; F Leoncini; E Meani; M Venditti; F Mazzotta
Journal:  Infection       Date:  2009-11-10       Impact factor: 7.455

Review 10.  Two-stage procedure in the treatment of late chronic hip infections--spacer implantation.

Authors:  Mohamed Sukeik; Fares S Haddad
Journal:  Int J Med Sci       Date:  2009-09-02       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.